Dr. Shaya has advanced training and expertise in formulary development and management, as well as medication therapy management (MTM) programs. She has built research capacity to support all stages of drug development and policy, from pre-clinical trials to post-marketing surveillance. She has experience in developing clinical, economic, policy, decision analysis and budget impact models. She works with Medicare and Medicaid programs and commercial plans, to guide drug formulary management and coverage decisions. Her extra-mural research is supported by federal, state, commercial and foundation grants and contracts.
A member of the Pharmacy and Therapeutics committee at CareFirst BlueCross BlueShield, she also serves on the Editorial Advisory Boards of the Journal of Medical Economics, the Journal of Managed Care Pharmacy, Expert Review in Pharmacoeconomics and Outcomes Research, and P&T. She is a reviewer for and has published in peer-reviewed journals, including Circulation, The Lancet, The Lancet Diabetes, The Lancet Infectious Disease, Health Affairs and Archives of Internal Medicine. She has reviewed over 400 papers for publication in these journals and has published over 200 articles. She regularly presents at national and international scientific and policy meetings, with over 250 presentations and posters to date. She has also been an invited speaker at Harvard Medical School, the Post-Approval Summit, the Johns Hopkins University Bloomberg School of Public Health, the Institute of Medicine (on stockpiling policies) and various other federal, academic or industry venues. Her current research focuses on the implementation of new Medicare policies, patient-centered approach to care and research, comparative effectiveness, and the development of methods to inform optimal clinical and coverage decisions.
Dr. Shaya has served as the Chair of the State of Maryland Governor’s Advisory Council on Hepatitis C and Diseases of the Liver, and heads the MVP (Maryland Cardiovascular Health) Program and has served as the Co-PI of a large grant from the National Heart, Lung, and Blood Institute, (NHLBI) to develop and implement a research partnership program between academia and a community-based health system in the Health Enterprise Zone in West Baltimore.
She serves on the Advisory Council for Clinical Pharmacology and Pharmaceutical Sciences at the Food and Drug Administration (FDA), the Board of the Delmarva Foundation for Medical Care (chairing the Education, Performance and Evaluation Committee and serving on the Compliance Committee), the Quality Health Foundation, and the Health Services and Value Research Review (HSVR) study section and special emphasis panels for the Agency for Health Quality Research (AHRQ). Her translational medicine work is based on public-private partnerships and community engagement initiatives aimed at reducing the burden of chronic disease.
Dr. Shaya teaches in various clinical and graduate policy courses and advises and mentors pharmacy, medical, graduate and post-doctoral students and junior faculty. Her mentees and students have 100% career placement rate and have taken positions in government, academia, consulting, non-profit organizations and the healthcare industry. She serves as Chapter Advisor for the Academy of Managed Care Pharmacy and has lead her team to several national wins in the annual pharmacy and therapeutics (P&T) formulary competition.
She is a member of the Executive Council at the School of Pharmacy, the Faculty Senate, the Facutly Senate Advisory Committee, and the Council of University System Faculty (CUSF) at the University of Maryland. She has led the design of the new curriculum, serving as chair of the Curriculum Committee, and the Assessment Committee at the School. She has also chaired various search committees at the University and other organizations she serves.
Dr. Shaya obtained her PhD in Health Policy, Finance and Management from the Johns Hopkins Bloomberg School of Public Health (with a minor Health Economics), her doctoral health economics degree (DESS) from the Sorbonne University Paris-IX Dauphine and her Masters in Public Health (MPH) and BSc in Pharmaceutical Sciences from the American University of Beirut.
She is also very involved in her local community, volunteers on the boards of various community engagement boards (e.g. Sinai hospital), at Our Daily Bread and at fund raising events for various health and education causes. She is also active with the World Trade Center Institute programs sponsored by the US Department of State. She is fluent in English, French, Arabic and Spanish.